Mario Gabelli's ESPR Position Overview
Mario Gabelli (via Gamco Investors, Inc. Et Al) currently holds 172,500 shares of Esperion Therapeutics, Inc. (ESPR) worth $545,100, representing 0.00% of the portfolio. First purchased in 2026-Q2, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Mario Gabelli has initiated a new position in ESPR, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Mario Gabelli's Esperion Therapeutics (ESPR) Holding Value Over Time
Track share changes against reported price movement
Quarterly Esperion Therapeutics (ESPR) Trades by Mario Gabelli
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +172,500 | New Buy | 172,500 | $3.16 |
Mario Gabelli's Esperion Therapeutics Investment FAQs
Mario Gabelli first purchased Esperion Therapeutics, Inc. (ESPR) in Q2 2026, acquiring 172,500 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Mario Gabelli has held Esperion Therapeutics, Inc. (ESPR) for 1 quarters since Q2 2026.
Mario Gabelli's largest addition to Esperion Therapeutics, Inc. (ESPR) was in Q2 2026, adding 172,500 shares worth $545,100.
According to the latest 13F filing for Q2 2026, Mario Gabelli's firm, Gamco Investors, Inc. Et Al, owns 172,500 shares of Esperion Therapeutics, Inc. (ESPR), valued at approximately $545,100.
As of the Q2 2026 filing, Esperion Therapeutics, Inc. (ESPR) represents approximately 0.00% of Mario Gabelli's publicly disclosed stock portfolio, making it one of their key holdings.
Mario Gabelli's peak holding in Esperion Therapeutics, Inc. (ESPR) was 172,500 shares, as reported at the end of Q2 2026.